Financial Year |
March 31 2023 |
Monetary Funds |
287,637,423.28 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
205,714,946.17 |
Advances to Suppliers |
14,799,251.64 |
Other Receivables |
2,255,685.41 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
77,266,603.08 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
23,795,850.53 |
Total Current Assets |
611,469,760.11 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
678,699,162.79 |
Under-construction Projects |
65,576,699.76 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
191,716,875.15 |
R&D expenses |
-- |
Goodwill |
103,658,085.59 |
Long-Term Deferred and Prepaid Expenses |
359,787.34 |
Deferred Income Tax Assets |
33,755,878.91 |
Other Non-Current Assets |
47,272,038.38 |
Sub-Total of Non-Current Assets |
1,148,883,169.66 |
Total Assets |
1,760,352,929.77 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
30,458,735.75 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
7,130,126.71 |
Taxes Payable |
3,270,180.27 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
38,806,817.39 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
50,059,277.78 |
Other Current Liabilities |
21,848,502.89 |
Sub-Total of Current Liabilities |
394,046,781.99 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
16,449,551.81 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
18,989,181.16 |
Total Liabilities |
413,035,963.15 |
Paid-In Capital(Or Share Stock) |
141,500,000.00 |
Capital Surplus |
485,508,340.75 |
Surplus Reserve |
46,721,146.93 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
645,984,517.70 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,347,316,966.62 |
Owner's Equity(Stockholder's Equity) |
1,347,316,966.62 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,760,352,929.77 |